US20040197405A1 - Multiparticulate modified release composition - Google Patents

Multiparticulate modified release composition Download PDF

Info

Publication number
US20040197405A1
US20040197405A1 US10/827,689 US82768904A US2004197405A1 US 20040197405 A1 US20040197405 A1 US 20040197405A1 US 82768904 A US82768904 A US 82768904A US 2004197405 A1 US2004197405 A1 US 2004197405A1
Authority
US
United States
Prior art keywords
active ingredient
modified release
component
composition according
release composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/827,689
Inventor
John Devane
Paul Stark
Niall Fanning
Gurvinder Singh Rekhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECRO GAINESVILLE LLC
Original Assignee
Elan Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US10672698P priority Critical
Priority to PCT/US1999/025632 priority patent/WO2000025752A1/en
Priority to US09/566,636 priority patent/US6228398B1/en
Priority to US09/850,425 priority patent/US6730325B2/en
Priority to US10/331,754 priority patent/US6902742B2/en
Priority to US10/354,483 priority patent/US6793936B2/en
Application filed by Elan Corp PLC filed Critical Elan Corp PLC
Priority to US10/827,689 priority patent/US20040197405A1/en
Publication of US20040197405A1 publication Critical patent/US20040197405A1/en
Priority claimed from US11/372,857 external-priority patent/US20060240105A1/en
Priority claimed from US11/568,925 external-priority patent/US20090297602A1/en
Priority claimed from US11/422,226 external-priority patent/US20080118556A1/en
Priority claimed from US11/569,481 external-priority patent/US20090297597A1/en
Priority claimed from US11/479,013 external-priority patent/US20100247636A1/en
Priority claimed from US11/478,891 external-priority patent/US20070160675A1/en
Priority claimed from US11/558,202 external-priority patent/US20070122481A1/en
Priority claimed from US11/768,154 external-priority patent/US20080113025A1/en
Priority claimed from US11/768,169 external-priority patent/US20080102121A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22312931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040197405(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Assigned to ELAN PHARMA INTERNATIONAL LIMITED reassignment ELAN PHARMA INTERNATIONAL LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ELAN CORPORATION, PLC
Priority claimed from US12/209,728 external-priority patent/US20090149479A1/en
Assigned to ELAN CORPORATION, PLC reassignment ELAN CORPORATION, PLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEVANE, JOHN G, FANNING, NIALL M. M., STARK, PAUL
Assigned to MORGAN STANLEY SENIOR FUNDING, INC. reassignment MORGAN STANLEY SENIOR FUNDING, INC. PATENT SECURITY AGREEMENT (FIRST LIEN) Assignors: ALKERMES CONTROLLED THERAPEUTICS INC., ALKERMES PHARMA IRELAND LIMITED, ALKERMES, INC.
Assigned to MORGAN STANLEY SENIOR FUNDING, INC. reassignment MORGAN STANLEY SENIOR FUNDING, INC. PATENT SECURITY AGREEMENT (SECOND LIEN) Assignors: ALKERMES CONTROLLED THERAPEUTICS INC., ALKERMES PHARMA IRELAND LIMITED, ALKERMES, INC.
Assigned to EDT PHARMA HOLDINGS LIMITED reassignment EDT PHARMA HOLDINGS LIMITED ASSET TRANSFER AGREEMENT Assignors: ELAN PHARMA INTERNATIONAL LIMITED
Assigned to ALKERMES PHARMA IRELAND LIMITED reassignment ALKERMES PHARMA IRELAND LIMITED NOTICE OF CHANGE IN REGISTERED OFFICE ADDRESS Assignors: ALKERMES PHARMA IRELAND LIMITED
Assigned to ALKERMES PHARMA IRELAND LIMITED reassignment ALKERMES PHARMA IRELAND LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: EDT PHARMA HOLDINGS LIMITED
Assigned to EDT PHARMA HOLDINGS reassignment EDT PHARMA HOLDINGS NOTICE OF CHANGE IN REGISTERED OFFICE ADDRESS Assignors: EDT PHARMA HOLDINGS
Assigned to ALKERMES, INC., ALKERMES CONTROLLED THERAPEUTICS INC., ALKERMES PHARMA IRELAND LIMITED reassignment ALKERMES, INC. RELEASE BY SECURED PARTY (SECOND LIEN) Assignors: MORGAN STANLEY SENIOR FUNDING, INC.
Assigned to ALKERMES SCIENCE ONE LIMITED reassignment ALKERMES SCIENCE ONE LIMITED SECOND AMENDMENT TO INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT Assignors: ALKERMES PHARMA IRELAND LIMITED
Assigned to DARAVITA LIMITED reassignment DARAVITA LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ALKERMES SCIENCE ONE LIMITED
Assigned to DV TECHNOLOGY LLC reassignment DV TECHNOLOGY LLC ASSET TRANSFER AND LICENSE AGREEMENT Assignors: ALKERMES PHARMA IRELAND LIMITED
Assigned to ALKERMES PHARMA IRELAND LIMITED reassignment ALKERMES PHARMA IRELAND LIMITED BUSINESS TRANSFER AGREEMENT Assignors: DARAVITA LIMITED
Assigned to ORBIMED ROYALTY OPPORTUNITIES II, LP reassignment ORBIMED ROYALTY OPPORTUNITIES II, LP SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RECRO TECHNOLOGY LLC
Assigned to RECRO TECHNOLOGY LLC reassignment RECRO TECHNOLOGY LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DV TECHNOLOGY LLC
Assigned to DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED) reassignment DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED) RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MORGAN STANLEY SENIOR FUNDING, INC.
Assigned to RECRO GAINESVILLE LLC reassignment RECRO GAINESVILLE LLC MERGER (SEE DOCUMENT FOR DETAILS). Assignors: RECRO TECHNOLOGY LLC
Assigned to ATHYRIUM OPPORTUNITIES III ACQUSITION LP reassignment ATHYRIUM OPPORTUNITIES III ACQUSITION LP SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RECRO GAINESVILLE LLC
Assigned to RECRO GAINESVILLE LLC (F/K/A RECRO TECHNOLOGY LLC) reassignment RECRO GAINESVILLE LLC (F/K/A RECRO TECHNOLOGY LLC) RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: ORBIMED ROYALTY OPPORTUNITIES II, LP
Assigned to ATHYRIUM OPPORTUNITIES III ACQUISITION LP reassignment ATHYRIUM OPPORTUNITIES III ACQUISITION LP CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY'S NAME PREVIOUSLY RECORDED AT REEL: 044165 FRAME: 0783. ASSIGNOR(S) HEREBY CONFIRMS THE GRANT OF SECURITY INTEREST . Assignors: RECRO GAINESVILLE LLC
Application status is Abandoned legal-status Critical

Links